Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Worldwide Post-Market Surveillance Registry to Assess the Medigus Ultrasonic Surgical Endostapler (MUSE™) System for the Treatment of GERD

NCT02366169 is registered in ClinicalTrials.gov with Medigus Ltd as lead sponsor.

NCT NCT02366169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02366169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Worldwide Post-Market Surveillance Registry to Assess the Medigus Ultrasonic Surgical Endostapler (MUSE™) System for the Treatment of GERD
Lead sponsor
Medigus Ltd
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2015
Completion date
December 31, 2019
Enrollment
200 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease (gerd)